Cytokines, Plasma Immune Activation Markers, and Clinically Relevant Surrogate Markers in Human Immunodeficiency Virus Infection

Overview

Journal Clin Diagn Lab Immunol

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1998 Sep 8

PMID 9729522

Citations 25

Authors

J L Fahey

Affiliations

Soon will be listed here.

Citing Articles

Using Laboratory Test Results for Surveillance During a New Outbreak of Acute Hepatitis in 3-Week- to 5-Year-Old Children in the United Kingdom, the Netherlands, Ireland, and Curaçao: Observational Cohort Study.

Swets M, Kerr S, Mackenna B, Fisher L, van Wijnen M, Brandwagt D JMIR Public Health Surveill. 2025; 10:e55376.

PMID: 39864403 PMC: 11770233. DOI: 10.2196/55376.

Prevalence of Cytopenia and its Correlation with Immunosuppression in Naïve HIV-1 Infected Patients Initiating First-Line Antiretroviral Therapy: A Pilot Study.

Usman A, Balogun O, Shuaib B, Musa B, Yusuf A, Ajayi E Infect Chemother. 2024; 55(4):479-489.

PMID: 38183393 PMC: 10771947. DOI: 10.3947/ic.2023.0080.

Association of Fatty Acid Signatures with HIV Viremia in Pregnancy.

Fisher S, Jao J, Yee L, Serghides L, Chadwick E, Jacobson D AIDS Res Hum Retroviruses. 2023; 40(4):257-267.

PMID: 37772708 PMC: 11040191. DOI: 10.1089/AID.2023.0040.

A high-throughput screening RT-qPCR assay for quantifying surrogate markers of immunity from PBMCs.

Browne D, Kelly A, Brady J, Doolan D Front Immunol. 2022; 13:962220.

PMID: 36110843 PMC: 9469018. DOI: 10.3389/fimmu.2022.962220.

Evaluation of the Immunoprotective Potential of Recombinant Paraflagellar Rod Proteins of in Mice.

Maharana B, Sudhakar N, Jawalagatti V, Saravanan B, Blake D, Tewari A Vaccines (Basel). 2020; 8(1).

PMID: 32059486 PMC: 7157580. DOI: 10.3390/vaccines8010084.

References

Romagnani S, Del Prete G, Manetti R, RAVINA A, Annunziato F, De Carli M . Role of TH1/TH2 cytokines in HIV infection. Immunol Rev. 1994; 140:73-92. DOI: 10.1111/j.1600-065x.1994.tb00865.x. View

Richman D, Bozzette S . The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis. 1994; 169(5):968-74. DOI: 10.1093/infdis/169.5.968. View

Lyamuya E, Kagoma C, Mbena E, Urassa W, Pallangyo K, Mhalu F . Evaluation of the FACScount, TRAx CD4 and Dynabeads methods for CD4 lymphocyte determination. J Immunol Methods. 1996; 195(1-2):103-12. DOI: 10.1016/0022-1759(96)00094-4. View

Lane H, Depper J, Greene W, Whalen G, Waldmann T, Fauci A . Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med. 1985; 313(2):79-84. DOI: 10.1056/NEJM198507113130204. View

Pal R, Garzino-Demo A, Markham P, Burns J, Brown M, Gallo R . Inhibition of HIV-1 infection by the beta-chemokine MDC. Science. 1997; 278(5338):695-8. DOI: 10.1126/science.278.5338.695. View

Hofmann B, Bygbjerg I, Dickmeiss E, Faber V, Frederiksen B, Gaub J . Prognostic value of immunologic abnormalities and HIV antigenemia in asymptomatic HIV-infected individuals: proposal of immunologic staging. Scand J Infect Dis. 1989; 21(6):633-43. DOI: 10.3109/00365548909021691. View

Homburger H, Rosenstock W, Paxton H, Paton M, Landay A . Assessment of interlaboratory variability of immunophenotyping. Results of the College of American Pathologists Flow Cytometry Survey. Ann N Y Acad Sci. 1993; 677:43-9. DOI: 10.1111/j.1749-6632.1993.tb38762.x. View

Bass H, Hardy W, Mitsuyasu R, Taylor J, Wang Y, Fischl M . The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals. J Acquir Immune Defic Syndr (1988). 1992; 5(3):215-21. View

Zangerle R, Gallati H, Sarcletti M, Weiss G, Denz H, Wachter H . Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation. J Acquir Immune Defic Syndr (1988). 1994; 7(1):79-85. View

10.

Choi S, Lagakos S, Schooley R, Volberding P . CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann Intern Med. 1993; 118(9):674-80. DOI: 10.7326/0003-4819-118-9-199305010-00003. View

11.

Huber C, Batchelor J, Fuchs D, Hausen A, Lang A, Niederwieser D . Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med. 1984; 160(1):310-6. PMC: 2187425. DOI: 10.1084/jem.160.1.310. View

12.

Godfried M, van der Poll T, Weverling G, Mulder J, Jansen J, van Deventer S . Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J Infect Dis. 1994; 169(4):739-45. DOI: 10.1093/infdis/169.4.739. View

13.

Fahey J, Taylor J, Manna B, Nishanian P, Aziz N, Giorgi J . Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements. AIDS. 1998; 12(13):1581-90. DOI: 10.1097/00002030-199813000-00004. View

14.

Sarna G, Machleder H, Collins J, Bonavida B, Jacobs E, Hawkins R . A comparative study of intravenous versus intralymphatic interleukin-2, with assessment of effects of interleukin-2 on both peripheral blood and thoracic-duct lymph. J Immunother Emphasis Tumor Immunol. 1994; 15(2):140-6. DOI: 10.1097/00002371-199402000-00008. View

15.

Salazar-Gonzalez J, Martinez-Maza O, Aziz N, Kolberg J, Yeghiazarian T, Shen L . Relationship of plasma HIV-RNA levels and levels of TNF-alpha and immune activation products in HIV infection. Clin Immunol Immunopathol. 1997; 84(1):36-45. DOI: 10.1006/clin.1997.4364. View

16.

Graham N . The role of immunologic and viral markers in predicting clinical outcome in HIV infection. AIDS. 1996; 10 Suppl 5:S21-5. DOI: 10.1097/00002030-199612005-00004. View

17.

MELMED R, Taylor J, Detels R, Bozorgmehri M, Fahey J . Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS. J Acquir Immune Defic Syndr (1988). 1989; 2(1):70-6. View

18.

Bass H, Nishanian P, Hardy W, Mitsuyasu R, Esmail E, Cumberland W . Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens. Clin Immunol Immunopathol. 1992; 64(1):63-70. DOI: 10.1016/0090-1229(92)90060-2. View

19.

Mellors J, Munoz A, Giorgi J, Margolick J, Tassoni C, Gupta P . Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997; 126(12):946-54. DOI: 10.7326/0003-4819-126-12-199706150-00003. View

20.

Cocchi F, Devico A, Garzino-Demo A, Arya S, Gallo R, Lusso P . Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 1995; 270(5243):1811-5. DOI: 10.1126/science.270.5243.1811. View